Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05960461 · ClinicalTrials.gov registry record · NA

Families Moving Forward (FMF) Connect Pro for Mental Health Providers

A NA study of Fetal Alcohol Spectrum Disorders, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
1
Study location

NCT05960461 is a NA study of Fetal Alcohol Spectrum Disorders that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 250 participants, above the 81-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05960461, a NA study of Fetal Alcohol Spectrum Disorders, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol exposure, diagnose fetal alcohol spectrum disorders (FASD), and support families in using the FMF Connect caregiver app. Two different training methods will be compared with a waitlist group in this study. The first training method involves 13-sessions of tele-mentoring using an Extension of Community Healthcare Outcomes (ECHO) approach. The second training method involves a self-directed approach in which providers will access similar content in any asynchronous format on a website. The main questions this study aims to answer are: * What is the proportion of agencies and providers who accept and participate in the clinical trial (Reach)? * Do study groups differ on provider outcome measures of Effectiveness (clients screened/diagnosed), Adoption (provider change in knowledge, self-efficacy), Implementation (practice change, FMF Connect Pro Dashboard usage), and Maintenance of FASD-informed care practice change? All mental health providers in the study will complete online assessments at study entry, 6 months, and 12 months.

Conditions Studied

Fetal Alcohol Spectrum Disorders

Interventions

  • BEHAVIORAL FMF (Families Moving Forward) Connect Pro
  • BEHAVIORAL ECHO (Extension of Community Healthcare Outcomes) implementation.
  • BEHAVIORAL Self-Directed Learning implementation.

Study Locations (1)

New York

  • Mt. Hope Family Center - Rochester

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-03-22
Est. Completion 2027-04-30
Phase NA

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05960461

The ClinicalTrials.gov registry entry for NCT05960461 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 81-participant average among 10 other Fetal Alcohol Spectrum Disorders trials with a reported enrollment target (209% higher). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fetal Alcohol Spectrum Disorders appearing as the primary indexed condition, and to 3 interventions - of which FMF (Families Moving Forward) Connect Pro is the first listed.

NCT05960461 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05960461 about?

NCT05960461 is a clinical study titled "Families Moving Forward (FMF) Connect Pro for Mental Health Providers". The goal of this clinical trial is to test a new provider-assisted version of the caregiver Families Moving Forward (FMF) Connect app ("FMF Connect Pro") with mental health providers in the United States. In FMF Connect Pro, mental health providers learn to do routine screening for prenatal alcohol ...

What is the current status of trial NCT05960461?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-22. Estimated completion is 2027-04-30.

What conditions does trial NCT05960461 study?

This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorders.

What interventions are being tested in trial NCT05960461?

The interventions under investigation include: FMF (Families Moving Forward) Connect Pro (BEHAVIORAL), ECHO (Extension of Community Healthcare Outcomes) implementation. (BEHAVIORAL), Self-Directed Learning implementation. (BEHAVIORAL).

Who is sponsoring clinical trial NCT05960461?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05960461 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fetal Alcohol Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fetal Alcohol Spectrum Disorders

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.